Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Biocon: anticancer biologics still largely unaffordable

16.01.2014 / Scripintelligence

Biocon, which is set to launch soon in India a biosimilar version of Roche's Herceptin (trastuzumab), indicated how the number of days' wages required to purchase a month's course of cancer antibody treatment varied from 371 in Southeast Asia, 1,285 in…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: